First Financial Corp’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $93.9K | Hold |
599
| – | – | 0.03% | 174 |
|
|
2026
Q1 | $91.5K | Hold |
599
| – | – | 0.04% | 168 |
|
|
2025
Q4 | $82.6K | Hold |
599
| – | – | 0.03% | 175 |
|
|
2025
Q3 | $76.8K | Hold |
599
| – | – | 0.03% | 181 |
|
|
2025
Q2 | $72.5K | Sell |
599
-9
| -1% | -$1.01K | 0.03% | 176 |
|
|
2025
Q1 | $67.8K | Hold |
608
| – | – | 0.03% | 195 |
|
|
2024
Q4 | $59.2K | Buy |
608
+1
| +0.2% | +$107 | 0.03% | 208 |
|
|
2024
Q3 | $69.8K | Sell |
607
-15
| -2% | -$1.7K | 0.03% | 185 |
|
|
2024
Q2 | $66.2K | Hold |
622
| – | – | 0.03% | 192 |
|
|
2024
Q1 | $60.2K | Buy |
622
+8
| +1% | +$820 | 0.03% | 206 |
|
|
2023
Q4 | $62K | Hold |
614
| – | – | 0.03% | 215 |
|
|
2023
Q3 | $62.5K | Hold |
614
| – | – | 0.04% | 207 |
|
|
2023
Q2 | $62K | Hold |
614
| – | – | 0.04% | 186 |
|
|
2023
Q1 | $56.5K | Hold |
614
| – | – | 0.04% | 194 |
|
|
2022
Q4 | $55.7K | Sell |
614
-250
| -29% | -$21.1K | 0.03% | 194 |
|
|
2022
Q3 | $66K | Hold |
864
| – | – | 0.04% | 174 |
|
|
2022
Q2 | $73K | Sell |
864
-40
| -4% | -$3.51K | 0.05% | 166 |
|
|
2022
Q1 | $80K | Hold |
904
| – | – | 0.05% | 175 |
|
|
2021
Q4 | $79K | Hold |
904
| – | – | 0.05% | 171 |
|
|
2021
Q3 | $74K | Hold |
904
| – | – | 0.05% | 172 |
|
|
2021
Q2 | $82K | Hold |
904
| – | – | 0.05% | 164 |
|
|
2021
Q1 | $77K | Hold |
904
| – | – | 0.05% | 164 |
|
|
2020
Q4 | $86K | Sell |
904
-16
| -2% | -$1.4K | 0.06% | 150 |
|
|
2020
Q3 | $80K | Hold |
920
| – | – | 0.07% | 143 |
|
|
2020
Q2 | $81K | Hold |
920
| – | – | 0.07% | 141 |
|
|
2020
Q1 | $76K | Hold |
920
| – | – | 0.07% | 140 |
|
|
2019
Q4 | $87K | Hold |
920
| – | – | 0.06% | 159 |
|
|
2019
Q3 | $80K | Hold |
920
| – | – | 0.06% | 161 |
|
|
2019
Q2 | $84K | Sell |
920
-107
| -10% | -$9.06K | 0.07% | 141 |
|
|
2019
Q1 | $88K | Hold |
1,027
| – | – | 0.07% | 152 |
|
|
2018
Q4 | $79K | Sell |
1,027
-50
| -5% | -$3.89K | 0.06% | 158 |
|
|
2018
Q3 | $84K | Hold |
1,077
| – | – | 0.06% | 166 |
|
|
2018
Q2 | $73K | Hold |
1,077
| – | – | 0.05% | 173 |
|
|
2018
Q1 | $78K | Sell |
1,077
-231
| -18% | -$17.6K | 0.06% | 173 |
|
|
2017
Q4 | $98K | Sell |
1,308
-389
| -23% | -$29.4K | 0.06% | 161 |
|
|
2017
Q3 | $130K | Sell |
1,697
-1,864
| -52% | -$141K | 0.09% | 143 |
|
|
2017
Q2 | $267K | Sell |
3,561
-9,315
| -72% | -$660K | 0.17% | 92 |
|
|
2017
Q1 | $857K | Sell |
12,876
-2,352
| -15% | -$157K | 0.54% | 40 |
|
|
2016
Q4 | $994K | Buy |
15,228
+835
| +6% | +$54.2K | 0.59% | 37 |
|
|
2016
Q3 | $1.02M | Buy |
14,393
+646
| +5% | +$47.1K | 0.6% | 37 |
|
|
2016
Q2 | $1.02M | Buy |
13,747
+6,554
| +91% | +$453K | 0.59% | 39 |
|
|
2016
Q1 | $467K | Buy |
7,193
+441
| +7% | +$30K | 0.24% | 94 |
|
|
2015
Q4 | $521K | Sell |
6,752
-32
| -0.5% | -$2.54K | 0.28% | 90 |
|
|
2015
Q3 | $559K | Sell |
6,784
-893
| -12% | -$79.5K | 0.31% | 79 |
|
|
2015
Q2 | $676K | Buy |
7,677
+63
| +0.8% | +$5.78K | 0.34% | 71 |
|
|
2015
Q1 | $672K | Buy |
7,614
+31
| +0.4% | +$2.75K | 0.34% | 75 |
|
|
2014
Q4 | $629K | Buy |
7,583
+446
| +6% | +$37K | 0.31% | 76 |
|
|
2014
Q3 | $601K | Buy |
7,137
+2,065
| +41% | +$167K | 0.3% | 81 |
|
|
2014
Q2 | $411K | Sell |
5,072
-837
| -14% | -$65.8K | 0.2% | 108 |
|
|
2014
Q1 | $451K | Hold |
5,909
| – | – | 0.22% | 105 |
|
|
2013
Q4 | $425K | Sell |
5,909
-2,723
| -32% | -$189K | 0.2% | 104 |
|
|
2013
Q3 | $594K | Hold |
8,632
| – | – | 0.29% | 85 |
|
|
2013
Q2 | $547K | Buy |
+8,632
| New | +$562K | 0.27% | 90 |
|
Other funds holding NVS
First Financial Corp's NVS Position: Q2 2026 in Review
First Financial Corp held its Novartis (NVS) position steady in Q2 2026 at 599 shares worth $93.9K. The position accounts for 0.03% of the portfolio, ranked #174.
First Financial Corp first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.02M in Q3 2016. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- First Financial Corp held 599 shares of Novartis worth $93.9K as of Q2 2026.
- First Financial Corp left its Novartis share count unchanged in Q2 2026.
- Novartis made up 0.03% of First Financial Corp's portfolio in Q2 2026, its #174 holding.
- First Financial Corp first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
- First Financial Corp's Novartis position peaked at $1.02M in Q3 2016.
- 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on First Financial Corp's 13F filing for Q2 2026, filed 7 Jul 2026.